A Drug Molecule-Modified Graphene Field-Effect Transistor Nanosensor for Rapid, Label-Free, and Ultrasensitive Detection of Estrogen Receptor α Protein-Reference-Cited by-同舟云学术

A Drug Molecule-Modified Graphene Field-Effect Transistor Nanosensor for Rapid, Label-Free, and Ultrasensitive Detection of Estrogen Receptor α Protein

Published:2024-02-15 Issue:8 Volume:96 Page:3454-3461
ISSN:0003-2700
Container-title:Analytical Chemistry
language:en
Short-container-title:Anal. Chem.

Author:

Ming Pinghong¹²,Li Jiahao¹^ORCID,Yang Lu³,Yu Yi¹,Tang Lina¹,Zhou Haibing⁴^ORCID,Zhang Zhi-Yong⁵^ORCID,Zhang Guo-Jun¹⁶^ORCID

Affiliation:

1. School of Laboratory Medicine, Hubei University of Chinese Medicine, 16 Huangjia Lake West Road, Wuhan 430065, P. R. China

2. Department of Clinical Laboratory, The People’s Hospital of Longhua, Shenzhen 518109, P. R. China

3. Department of Radiology, The Affiliated Hospital of Southwest Medical University, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou 646000, P. R. China

4. Hubei Provincial Key Laboratory of Developmentally Originated Disease, State Key Laboratory of Virology, Wuhan University School of Pharmaceutical Sciences, Wuhan 430071, P. R. China

5. Key Laboratory for the Physics and Chemistry of Nanodevices and Center for Carbon-based Electronics, School of Electronics, Peking University, Beijing 100871, P. R. China

6. Hubei Shizhen Laboratory, Hubei University of Chinese Medicine, 16 Huangjia Lake West Road, Wuhan 430065, P. R. China

Funder

National Key Research and Development Program of China

Special Project of Central Government for Local Science and Technology Development of Hubei Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.3c04809

Reference47 articles.

1. Estrogen receptor interaction with estrogen response elements

2. Highly sensitive and reversible silicon nanowire biosensor to study nuclear hormone receptor protein and response element DNA interactions

3. Quantification of estrogen receptor α and β expression in sporadic breast cancer

4. 17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer